Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

Trading in the Company’s common stock was suspended on Nasdaq effective with the ... receptor modulator being developed as a potential treatment for acute and chronic neuropathic pain secondary to ...

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

Occasionally, we might experience numbness in our legs. Isolated incidents usually aren't a cause for concern, but if they ...

ADCs, a form of guided missile delivering cytotoxic drugs ("payloads") precisely into the cancer cells via the antibody ...

In 2020, the U.S. FDA approved the product for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults ... Ensure that dosage and administration ...

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

- The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

NEW RESEARCH presented at EASD 2024 revealed that maternal Type 1 diabetes (T1D) provides long-term relative protection ...